U.S., May 10 -- ClinicalTrials.gov registry received information related to the study (NCT06964776) titled 'A Study of LY4268989 (MORF-057) in Healthy Participants' on May 01.
Brief Summary: The purpose of this study is to measure the body's absorption and processing of the study drug, the study drug's effect on the body, safety, and tolerability with LY4268989 (MORF-57) in healthy participants, including Japanese and Chinese participants
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: LY4268989
Administered orally
DRUG: Placebo
Administered placebo
DRUG: Midazolam
Administered orally
DRUG: Midazolam
Administered intravenously (IV)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: ...